Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2021 | 08-2020 | 08-2019 | 08-2018 | 08-2017 | |
| Sales | 2,703 | 2,710 | 2,703 | 2,449 | 2,456 |
| Cost of Goods | N/A | N/A | 90 | -86 | 187 |
| Gross Profit | 2,703 | 2,710 | 2,613 | 2,535 | 2,269 |
| Operating Expenses | 26,926 | 14,467 | 17,334 | 15,976 | 13,227 |
| Operating Income | -24,223 | -11,757 | -14,631 | -13,527 | -10,771 |
| Interest Expense | 8 | 444 | 485 | 103 | 101 |
| Other Income | 1,242 | 690 | 1,061 | 903 | 792 |
| Pre-tax Income | -22,989 | -11,511 | -14,055 | -12,727 | -10,080 |
| Income Tax | N/A | N/A | 300 | N/A | 400 |
| Net Income Continuous | -22,989 | -11,511 | -14,355 | -12,727 | -10,480 |
| Minority Interests | -751 | N/A | N/A | N/A | N/A |
| Net Income | $-22,238 | $-11,511 | $-14,355 | $-12,727 | $-10,480 |
| EPS Basic Total Ops | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 |
| EPS Basic Continuous Ops | -0.81 | -0.56 | -0.82 | -0.86 | -0.79 |
| EPS Diluted Total Ops | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 |
| EPS Diluted Continuous Ops | -0.81 | -0.56 | -0.82 | -0.86 | -0.79 |
| EBITDA(a) | $-24,146 | $-11,750 | $-14,623 | $-13,521 | $-10,766 |